Investor Presentation • Dec 8, 2022
Investor Presentation
Open in ViewerOpens in native device viewer
December 2022









To be the most trusted and reliable systems partner in the commercial vehicle industry

Diversified, asset-light and resilient business model

Aftermarket Powerhouse safeguarding profitability in crisis times
Driven by global megatrends: Electrification, digitalisation, automated driving
SAF-HOLLAND + Haldex Scale & Market Position Create Firm Foundations For:




| SAF-HOLLAND | Haldex | ||||||
|---|---|---|---|---|---|---|---|
| Trailer Axles | Fifth Wheels | Landing Gear | Suspensions / Air Controls |
Foundation Brake |
|||
| Global positioning |
#1-2 | #2 | #2 | #1-3 | |||
| Regional positioning |
#1 EMEA #1 India #3 NA* |
#1 NA* #2 EMEA |
#2 NA* #2 EMEA |
#2 Europe: Air Disc Brakes, Trailer #1 Europe: Air Suspension, Trailer #3 Europe: Trailer EBS #1 Europe / NA: Brake Adjusters |
|||
| Top 3 positions across key products |


* EBS: Electronic Brake System; ABS: Anti-Lock Braking System

2 Significant Customer Benefits From Increasingly Integrated Mechatronic Offering

Sole system supplier worldwide for all chassis-related products






High share of aftermarket business effectively bolsters SAF-HOLLAND's resilience profile

~12,000 spare parts dealers and service stationsin more than 80 countries guarantee spare parts availability
Axle population in EMEA has more than tripled


Leading Service Network in Europe and North America: key asset for fleet customers and significant barrier to market entry
Counter-Balances volatility in OE industries and generates growth based on increasing product population in the field ("razor and blade" business model")




Investor Presentation December 2022 < 13 >
6 SAF-HOLLAND + Haldex Already Offer a Broad Range of Integrated Smart Solutions

The Future: In 2025+ Commercial Vehicles to roll out partially autonomous, electrified and connected


We have broadened our footprint and portfolio over the past several years. Now our focus lies on:
integration of Haldex with focus on achieving:

We are reviewing our combined R&D capabilities and intend to enhance our internal process:
We continue to be committed to providing shareholder payments to an appropriate level:
• It is our target to pay-out 40% - 50% of our available Net Income to our Shareholders
Capital allocation framework is designed to achieve enhanced (1) margins, (2) cash conversion, (3) asset turn and (4) returns





NOTE: 2021 average FX rate of 0.0986 SEK/EUR used; * TA: Trailer Axles; FW: Fifth Wheels; AS: Air Suspension; ADB: Air Disc Brakes; TEBS: Trailer Electronic Braking System; ABA: Automatic Brake Adjusters



120 140 160 Adj. EBIT and Adj. EBIT margin 2014 - 2022 (in EUR mn and %)

SAF-HOLLAND's resilient profile ensures robust profitability – even in times of crisis

0.0%
5.0%
10.0%
15.0%
20.0%
25.0%

Adj. EBIT by Quarter (in EUR million and % of sales)

2021 2022

Q1 Q2 Q3 Q4

2022



• Product mix, successfully implemented efficiency enhancement measures and automation steps in production in particular have a beneficial effect
2021 2022



| EUR MN | 12/31/ 2020 |
03/31/ 2021 |
06/30/ 2021 |
09/30/ 2021 |
12/31/ 2021 |
03/31 2022 |
06/30/ 2022 |
09/30/ 2022 |
|---|---|---|---|---|---|---|---|---|
| Inventories | 126.4 | 155.8 | 176.0 | 195.3 | 194.0 | 211.9 | 237.0 | 237.9 |
| Trade receivables |
95.3 | 130.0 | 148.9 | 147.2 | 136.3 | 176.1 | 184.6 | 187.0 |
| Trade payables |
-107.2 | -147.4 | -163.4 | -160.6 | -145.8 | -179.3 | -176.2 | -187.3 |
| NWC | 114.6 | 138.4 | 161.5 | 181.9 | 184.4 | 208.7 | 245.5 | 237.6 |
| Sales (LTM) | 959.5 | 961.7 | 1,091.4 | 1,175.6 | 1,246.6 | 1,330.7 | 1,411.7 | 1,497.5 |

ROCE = Adjusted EBIT (LTM) / (total equity + financial liabilities + lease liabilities + pension and other similar benefits ‐ cash and cash equivalents). Note: Capital employed 2012-2018 excluding lease liabilities (IFRS 16)




| March 17, 2022 | May 5, 2022 | July 28, 2022 | |
|---|---|---|---|
| Sales | EUR 1.15bn to EUR 1.3bn |
EUR 1.2bn to EUR 1.35bn |
EUR 1.4 bn to EUR 1.5 bn |
| Adjusted EBIT margin |
Significantly below 2021 |
6.5% to 7.0% | 7.0% to 8.0% |
| Capex ratio | 2% to 2.5% | 2% to 2.5% | Outlook slide from 2% to 2.5% Q3 |

| EUROPE | NORTH AMERICA |
SOUTH AMERICA |
CHINA | INDIA | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Truck | Trailer | Truck | Trailer | Truck | Trailer | Truck | Trailer | Truck | Trailer | |
| 2023 | -5% | -5% to -8% | -4% | -5 % | -9% | -8 % | +25% | +25% | +14% | +21% |
Down moderately from record levels amidst above-average age of truck and trailer park, share gains and growing resilient AM share

| Issuer & contact | Additional information | |
|---|---|---|
| SAF-HOLLAND SE Hauptstrasse 26 63856 Bessenbach |
ISIN DE000SAFH001 WKN SAFH00 Listing Prime Standard |
Frankfurt Stock Exchange |
| Stephan Haas Tel: +49 6095 301 – 803 |
Financial calendar | |
| Michael Schickling Tel: +49 6095 301 – 617 |
December 8, 2022 | Berenberg European Conference 2022 |
| Alexander Pöschl Tel: +49 6095 301 – 117 |
January 10, 2023 | Oddo BHF Forum 2023 |
| Email: [email protected] | January 17, 2023 | UniCredit /Kepler Cheuvreux German Corporate Conference 2023 |
| January 26, 2023 |
Capital Markets Day |
|


| in EUR thousands | Q3 2022 | Q3 2021 | Change absolute | Change in % |
|---|---|---|---|---|
| EBIT | 26,957 | 21,396 | 5,561 | 26.0% |
| EBIT margin in % | 6.7% | 6.8% | – | – |
| Additional depreciation and amortisation of property, plant and equipment and intangible assets from PPA |
2,416 | 2,258 | 158 | 7.0% |
| Valuation effects from call and put options | 35 | – | – | – |
| Restructuring and transactions costs | 5,271 | 699 | 4,572 | 687.9% |
| Impairment | 1,985 | – | – | – |
| Adjusted EBIT | 36,664 | 24,323 | 12,341 | 50.7% |
| Adjusted EBIT margin in % | 9.1% | 7.7% | – | – |
• Q3 2022 impairment includes China write-down

| Q1-Q3 | Q1-Q3 | Change | Change | Change | Change | |||
|---|---|---|---|---|---|---|---|---|
| in EUR thousands | 2022 | 2021 | abs. | in % | Q3 2022 | Q3 2021 | abs. | in % |
| Sales | 1,175,641 | 924,762 | 250,879 | 27.1% | 402,388 | 316,638 | 85,750 | 27.1% |
| Cost of sales | –979,212 | -759,384 | -219,828 | 28.9% | -330,703 | -263,281 | -69,422 | 26.4% |
| Gross profit | 196,429 | 165,378 | 31,051 | 18.8% | 69,685 | 53,357 | 16,328 | 30.6% |
| in % of sales | 16.7% | 17.9% | 17.3% | 16.9% | ||||
| Gross profit adjusted | 199,916 | 167,563 | 32,353 | 19,3% | 71,906 | 54,337 | 17,569 | 32.3% |
| in % of sales | 17.0% | 18.1% | 17.9% | 17.2% | ||||
| SG&A | -121,950 | -103,722 | -18,228 | 17.6% | -43,149 | -32,384 | -10,765 | 33.2% |
| in % of sales | -10.4% | -11.2% | -10.7% | -10.6% | ||||
| Operating profit | 74,479 | 61,656 | 12,823 | 20.8% | 26,536 | 20,973 | 5,563 | 26.5% |
| Share of net profit of | ||||||||
| investments accounted | 1,197 | 1,002 | 195 | 19.5% | 421 | 423 | -2 | -0.5% |
| for using the equity | ||||||||
| method | ||||||||
| EBIT | 75,676 | 62,658 | 13,018 | 20.8% | 26,957 | 21,396 | 5,561 | 26.0% |
| in % of sales | 6.4% | 6.8% | 6.7% | 6.8% | ||||
| EBIT adjusted | 92,281 | 71,276 | 21,005 | 29.5% | 36,664 | 24,323 | 12,341 | 50.7% |
| in % of sales | 7.8% | 7.7% | 9.1% | 7.7% | ||||
| Finance result | -6,510 | -6,597 | 87 | -1.3% | -3,167 | -2,174 | -993 | 45.7% |
| Result before taxes | 69,166 | 56,061 | 13,105 | 23.4% | 23,790 | 19,222 | 4,568 | 23.8% |
| Income taxes | -21,427 | -18,950 | -2,477 | 13.1% | -7,322 | -4,659 | -2,663 | 57.2% |
| Tax rate (%) | 30.9% | 33.8% | 30.8% | 24.2% | ||||
| Result for the period | 47,739 | 37,111 | 10,628 | 28.6% | 16,468 | 14,563 | 1,905 | 13.1% |
| in % of sales | 4.1% | 4.0% | 4.1% | 4.6% |

This presentation has been prepared by SAF-HOLLAND SE ("SAF-HOLLAND") and comprises written materials concerning SAF-HOLLAND and Haldex AB ("Haldex"). It contains summary information only and does not purport to be comprehensive and is not intended to be (and should not be used as) the sole basis of any analysis or other evaluation of SAF-HOLLAND, Haldex or its business. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of any information, including projections, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and, accordingly, neither SAF-HOLLAND nor any of the members of its management board or any of its officers, employees or advisors nor any other person shall have any responsibility or liability whatsoever (for negligence or otherwise) arising, directly or indirectly, from the use of this presentation, or its contents or otherwise in connection with this presentation.
This presentation contains certain statements related to our future business and financial performance and future events or developments involving SAF-HOLLAND, Haldex and/or the industry in which SAF-HOLLAND and Haldex operate that may constitute forward-looking statements. These statements may be identified by words such as "believes," "expects," "predicts," "intends," "projects," "plans," "estimates," "aims," "foresees," "anticipates," "targets," and similar expressions. Forward-looking statements are not historical facts, but solely opinions, views and forecasts which are based on current expectations and certain assumptions of SAF-HOLLAND's management or cited from third party sources which are uncertain and subject to risks. Actual events may differ significantly from the anticipated developments due to a number of factors, including without limitation, changes in general economic conditions, changes affecting the fair values of the assets held by SAF-HOLLAND and its subsidiaries, changes affecting interest rate levels, changes in competition levels, changes in laws and regulations, environmental damages, the potential impact of legal proceedings and actions and the SAF-HOLLAND Group's ability to achieve operational synergies from past or future acquisitions. Should any of these risks or uncertainties materialise or should underlying expectations not occur or assumptions prove to be incorrect, actual results, performance or achievements of SAF-HOLLAND may (negatively or positively) vary materially from those described, explicitly or implicitly, in the relevant forward-looking statement.
The information contained in this presentation, including any forward-looking statements expressed herein, speaks only as of the date hereof and reflects current legislation and the current business and financial affairs of the SAF-HOLLAND which are subject to change and audit. Neither the delivery of this presentation nor any further discussions of SAF-HOLLAND with any of the recipients thereof shall, under any circumstances, create any implication that there has been no change in the affairs of SAF-HOLLAND since such date. Consequently, SAF-HOLLAND neither accepts any responsibility for the future accuracy of the information contained in this presentation, including any forward-looking statements expressed herein, nor assumes any obligation, to update or revise this information to reflect subsequent events or developments which differ from those anticipated.
* This presentation is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would require any registration or licensing within such jurisdiction. This presentation is for information purposes only and does neither constitute an offer to sell securities, nor any recommendation of, or solicitation of an offer to buy, any securities of SAF-HOLLAND or Haldex in the United States, Germany or any other jurisdiction. In the United States, any securities may not be offered or sold absent registration or an exemption from registration under the U.S. Securities Act of 1933.
The information contained in this document has not been subject to any independent audit or review. Information derived from unaudited financial information should be read in conjunction with the relevant audited financial statements, including the notes thereto. Certain financial data included in the document consists of "non-IFRS financial measures". These non-IFRS financial measures may not be comparable to similarly titled measures presented by other companies, nor should they be construed as an alternative to other financial measures determined in accordance with IFRS. You are cautioned not to place undue reliance on any non-IFRS financial measures and ratios included herein.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.